Nicole Westerfeld

649 total citations
18 papers, 464 citations indexed

About

Nicole Westerfeld is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Epidemiology. According to data from OpenAlex, Nicole Westerfeld has authored 18 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 8 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Nicole Westerfeld's work include Mosquito-borne diseases and control (9 papers), Malaria Research and Control (9 papers) and vaccines and immunoinformatics approaches (7 papers). Nicole Westerfeld is often cited by papers focused on Mosquito-borne diseases and control (9 papers), Malaria Research and Control (9 papers) and vaccines and immunoinformatics approaches (7 papers). Nicole Westerfeld collaborates with scholars based in Switzerland, United States and Gambia. Nicole Westerfeld's co-authors include Rinaldo Zurbriggen, Gerd Pluschke, Andreas R. Kammer, Mario Amacker, Silvia Rasi, Shinji L. Okitsu, Christian Moser, Blaise Genton, Claudia Daubenberger and Marcel Tanner and has published in prestigious journals such as Blood, PLoS ONE and Vaccine.

In The Last Decade

Nicole Westerfeld

17 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole Westerfeld Switzerland 12 209 187 184 102 85 18 464
Sarah E. Silk United Kingdom 10 236 1.1× 179 1.0× 141 0.8× 69 0.7× 60 0.7× 21 449
Rajagopal Murugan Germany 9 137 0.7× 268 1.4× 193 1.0× 53 0.5× 52 0.6× 16 457
Adriana Bermúdez Colombia 15 311 1.5× 349 1.9× 167 0.9× 63 0.6× 51 0.6× 36 500
Iona J. Brian United Kingdom 5 236 1.1× 103 0.6× 110 0.6× 70 0.7× 74 0.9× 6 442
Yevel Flores-García United States 16 169 0.8× 397 2.1× 153 0.8× 110 1.1× 66 0.8× 37 592
Esteban Abot United States 10 155 0.7× 205 1.1× 161 0.9× 45 0.4× 29 0.3× 11 340
Thomas J. August United States 10 125 0.6× 114 0.6× 138 0.8× 71 0.7× 139 1.6× 13 377
Blanca Liliana Perlaza Colombia 12 165 0.8× 365 2.0× 140 0.8× 120 1.2× 30 0.4× 18 493
Stéphane Ascarateil Netherlands 6 148 0.7× 56 0.3× 222 1.2× 85 0.8× 73 0.9× 9 405
G Dobrescu United States 6 103 0.5× 154 0.8× 122 0.7× 48 0.5× 32 0.4× 8 295

Countries citing papers authored by Nicole Westerfeld

Since Specialization
Citations

This map shows the geographic impact of Nicole Westerfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole Westerfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole Westerfeld more than expected).

Fields of papers citing papers by Nicole Westerfeld

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole Westerfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole Westerfeld. The network helps show where Nicole Westerfeld may publish in the future.

Co-authorship network of co-authors of Nicole Westerfeld

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole Westerfeld. A scholar is included among the top collaborators of Nicole Westerfeld based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole Westerfeld. Nicole Westerfeld is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kato, Gregory J., Tomasz W. Kamiński, Paolo Rossato, et al.. (2025). G-CSF receptor is a signaling node linking thrombo-inflammation to vaso-occlusion in sickle cell disease: Target for a new phase 2 trial. Blood. 146(Supplement 1). 838–838.
2.
Cech, Patrick G., Maxmillian Mpina, Nicole Westerfeld, et al.. (2011). Virosome-Formulated Plasmodium falciparum AMA-1 & CSP Derived Peptides as Malaria Vaccine: Randomized Phase 1b Trial in Semi-Immune Adults & Children. PLoS ONE. 6(7). e22273–e22273. 52 indexed citations
3.
Thompson, Fiona M., David W. Porter, Shinji L. Okitsu, et al.. (2011). Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial. PLoS ONE. 6(2). 3 indexed citations
4.
Tamborrini, Marco, Nicole Westerfeld, Mario Amacker, et al.. (2011). Immunogenicity of a virosomally-formulated Plasmodium falciparum GLURP-MSP3 chimeric protein-based malaria vaccine candidate in comparison to adjuvanted formulations. Malaria Journal. 10(1). 359–359. 15 indexed citations
5.
Tamborrini, Marco, Markus S. Mueller, Nicole Westerfeld, et al.. (2009). Design and pre-clinical profiling of a Plasmodium falciparum MSP-3 derived component for a multi-valent virosomal malaria vaccine. Malaria Journal. 8(1). 314–314. 7 indexed citations
6.
Amacker, Mario, Nicole Westerfeld, Lucia Baldi, et al.. (2009). Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells. Vaccine. 27(46). 6415–6419. 15 indexed citations
7.
8.
Okitsu, Shinji L., Markus S. Mueller, Mario Amacker, et al.. (2008). Preclinical profiling of the immunogenicity of a two-component subunit malaria vaccine candidate based on virosome technology. Human Vaccines. 4(2). 106–114. 6 indexed citations
9.
Thompson, Fiona M., David W. Porter, Shinji L. Okitsu, et al.. (2008). Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial. PLoS ONE. 3(1). e1493–e1493. 83 indexed citations
10.
Daubenberger, Claudia, Gerd Pluschke, Rinaldo Zurbriggen, & Nicole Westerfeld. (2008). Development of influenza virosome-based synthetic malaria vaccines. Expert Opinion on Drug Discovery. 3(4). 415–423. 3 indexed citations
11.
Okitsu, Shinji L., Markus S. Mueller, Dong Bo Li, et al.. (2007). Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47kDa fragment both in sporozoites and merozoites. Peptides. 28(10). 2051–2060. 18 indexed citations
12.
Kammer, Andreas R., et al.. (2007). A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses. Vaccine. 25(41). 7065–7074. 46 indexed citations
13.
Okitsu, Shinji L., Olivier Silvie, Nicole Westerfeld, et al.. (2007). A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial. PLoS ONE. 2(12). e1278–e1278. 40 indexed citations
14.
Genton, Blaise, Gerd Pluschke, Lukas Degen, et al.. (2007). A Randomized Placebo-Controlled Phase Ia Malaria Vaccine Trial of Two Virosome-Formulated Synthetic Peptides in Healthy Adult Volunteers. PLoS ONE. 2(10). e1018–e1018. 44 indexed citations
15.
Moser, Christian, Mario Amacker, Andreas R. Kammer, et al.. (2007). Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations. Expert Review of Vaccines. 6(5). 711–721. 65 indexed citations
16.
Westerfeld, Nicole, Gerd Pluschke, & Rinaldo Zurbriggen. (2006). Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomes. Wiener klinische Wochenschrift. 118(S3). 50–57. 8 indexed citations
17.
Westerfeld, Nicole & Rinaldo Zurbriggen. (2005). Peptides delivered by immunostimulating reconstituted influenza virosomes. Journal of Peptide Science. 11(11). 707–712. 18 indexed citations
18.
Zurbriggen, Rinaldo, Mario Amacker, Andreas R. Kammer, et al.. (2005). Virosome-Based Active Immunization Targets Soluble Amyloid Species Rather Than Plaques in a Transgenic Mouse Model of Alzheimer's Disease. Journal of Molecular Neuroscience. 27(2). 157–166. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026